Alderley Park, UK – March 3rd 2025 – ImmunoKey Ltd., a UK-based biotechnology company pioneering next-generation CAR-T therapies for solid tumours, today announced it has been selected to join the Bruntwood Life Science Accelerator 2025 cohort.

The Bruntwood SciTech Accelerator is a prestigious programme designed to support high-growth science and technology businesses through tailored mentoring, strategic business support, and access to a thriving innovation ecosystem. ImmunoKey’s participation will help accelerate the development of its proprietary CARKey™ platform, as well as complementary technologies AmpliT™ and ReviT™, aimed at overcoming the major barriers faced by cell therapies in solid tumours.

“We are thrilled to be accepted into the Bruntwood SciTech Accelerator programme,” said Dr Gray Kueberuwa, CEO of ImmunoKey Ltd. “This opportunity will provide invaluable support as we progress towards our goal of delivering safe, effective CAR T-cell therapies for patients with solid cancers.”

The Bruntwood SciTech Accelerator provides companies with access to world-class mentors, funding networks, specialist facilities, and a dynamic community of entrepreneurs and innovators across the UK. ImmunoKey’s selection reflects the company's strong scientific foundation, experienced leadership team, and commitment to transforming cancer immunotherapy.

About ImmunoKey
ImmunoKey Ltd. is a UK-based biotechnology company developing next-generation CAR T-cell therapies to overcome the challenges of treating solid tumours. The company’s proprietary CARKey™ platform enables multi-antigen targeting while minimising off-tumour toxicity, supported by complementary technologies AmpliT™ and ReviT™ to enhance T-cell persistence and function in the tumour microenvironment. Backed by a leadership team with proven success in cell therapy development and clinical translation, ImmunoKey is advancing a pipeline of novel immunotherapies to address critical unmet needs in oncology.

For media inquiries, please contact:

ImmunoKey Ltd.: Dr. Gray Kueberuwa
Email: info@immunokey.co.uk
Website: https://www.immunokey.co.uk